Partnership aims to develop companion Dx for cancer drugs

09/20/2013 | GenomeWeb Daily News (free registration)

Ventana Medical Systems has entered into a development deal with German drugmaker Boehringer Ingelheim for undisclosed terms. The deal calls for Ventana to use its immunohistochemistry technology platform to create a companion diagnostic to Boehringer's cancer drugs that are under development.

View Full Article in:

GenomeWeb Daily News (free registration)

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
President/Chief Executive Officer
MedCost
Winston-Salem, NC
Consumer Directed Health Plan (CDH) Product Offering Manager
Blue Cross Blue Shield MA
Quincy, MA
Director, Payer Marketing
Avalere Health
Washington, DC
Actuary
Meridian Health Plan
Detroit, MI
Chief Medical Officer, Texas Children's Health Plan
Cejka Executive Search for Texas Childre's Health Plan
Houston, TX